← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

UTI - Money Market Fund

Direct Plan · Monthly IDCW · Money Market · Scheme code 133387

Fund houseUTI Mutual Fund
CategoryMoney Market
Plan & optionDirect · Monthly IDCW
History11.7 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 0.602.193.37 6.477.406.69 5.364.464.36
Money Market
category median
6.397.356.62 6.75

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 1.8% 0.51 0.53 -4.5%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the — months this scheme and its benchmark share.

Growth of ₹100 since launch

95120145170201620182020202220242026InvestVerdict

Drawdown from peak (%)

0%-2%-3%-5%201620182020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
576 -3.9% 3.9% 8.5% 9%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

UTI - Money Market Fund

Direct Plan · Monthly IDCW

Allocation

By asset

Debt96.74%
Cash & Equivalents3.25%

By market cap

Concentration

Number of stocks105
Top 5 stocks11.74%
Top 10 stocks20.63%
Top 20 stocks35.46%
Largest holding3.51%
Largest sectorCRISIL-A1+ 52.50%
Effective stocks83.7
Cash3.25%
InvestVerdict

UTI - Money Market Fund

Direct Plan · Monthly IDCW · holdings

Sector split

CRISIL-A1+ — 52.5%CARE-A1+ — 20.2%ICRA-A1+ — 12.4%SOV — 10.3%Cash & Equivalents — 3.3%Other — 1.3%CRISIL-A1+52.5%CARE-A1+20.2%ICRA-A1+12.4%SOV10.3%Cash & Equivalents3.3%Other1.3%
CRISIL-A1+52.50%
CARE-A1+20.15%
ICRA-A1+12.44%
SOV10.31%
Cash & Equivalents3.25%
IND-A1+1.03%
-0.31%

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹719,151 ₹119,151 7.19%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 30 Aug 2026.